Major factors fueling cancer profiling market growth are increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research. Factors restraining the market include high capital investments and low benefit ratio for biomarkers used in cancer profiling. Whereas, increasing demand for personalized medicine and point-of-care diagnostic tests in tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer profiling market.
- Agency -.
Complete report on “Cancer Profiling Market” spread across 173 Pages, Profiling 11 Companies and Supported with 22 Tables and 55 Figures is now available at www.reportsnreports.com/reports/268825-cancer-tumor-profiling-market-applications-personalized-medicine-diagnostics-biomarker-discovery-prognosis-research-technologies-ngs-qpcr-ihc-fish-cish-microarray-segments-genomics-proteomics-metabolomics-epigenetics-2013-2018.html .
The cancer profiling market is segmented into genomics, proteomics, epigenetics, and metabolomics. The genomics segment is expected to account for the largest share of the cancer profiling technique market in 2016.
Factors such as increasing investments, grants, and funds by governments; growing research in the field of genomics; and rising application of genomic sequencing in diagnostics are contributing to the growth of this segment.
- Agency -.
- Hospitals and clinics
- Research Institutes and clinical research organizations (CROs)
- Market Research and consulting firms
- Authorities framing reimbursement policies for use of cancer diagnostics
- Companies offering platforms/technologies for cancer diagnosis
- Market research and consulting firms
Growth in the cancer profiling market is driven by the increasing number of cancer cases, growing utility of biomarker in tumor profiling, and availability of funding for cancer research. In addition, the introduction and adoption of point-of-care diagnostic tests and development of personalized medicine are expected to offer growth opportunities for manufacturers of cancer profiling solutions.
However, high capital investments and low benefit ratio of biomarkers are restraining the growth of this market.
Click Now for PDF Sample Download of this Study Report
The cancer/tumor profiling market is analyzed both in terms of qualitative, that is, technological and quantitative, that is, revenue and perspectives. The technological analysis includes discussion on the advantages and capabilities of cancer/tumor profiling technologies and the various applications where cancer/tumor profiling can find a strong position in the healthcare industry.
The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
1 Illumina, Inc.
2 Qiagen N.V.
3 Neogenomics Laboratories, Inc.
4 HTG Molecular Diagnostics, Inc.
5 Genomic Health Inc.
6 Caris Life Sciences
7 Helomics Corporation
8 Nanostring Technologies, Inc.
9 Oxford Gene Technology
10 Ribomed Biotechnologies, Inc.
The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the cancer/tumor profiling market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
Connect for More Details for More details “Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)]” report @ www.reportsnreports.com/contacts/discount.aspx?name=268825 .
North America is expected to account for the largest share of the cancer profiling market in 2016. Increasing research funding and presence of a large number of market players and research institutes are propelling the growth of the North American cancer profiling market.
However, the Asia-Pacific region is estimated to witness the highest growth during the forecast period. The Asia-Pacific region is expected to grow at the highest CAGR of 20.4% in the forecast period.
In recent years, the Asia-Pacific market for cancer profiling has witnessed significant growth due to the rising incidence of cancer, increasing demand for better healthcare services in developing economies such as India and China, rising number of contract research organizations (CROs), and increasing focus of international players on emerging markets.
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.
For more information: